{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:29:07Z","timestamp":1793309347137,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007843","name":"Direktoratet for Utviklingssamarbeid","doi-asserted-by":"publisher","award":["QZA 0484 RSA 13\/0010"],"award-info":[{"award-number":["QZA 0484 RSA 13\/0010"]}],"id":[{"id":"10.13039\/100007843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Epidemiological data of cephalosporin-resistant\n                      <jats:italic>Enterobacterales<\/jats:italic>\n                      in Sub-Saharan Africa is still restricted, and in particular in Mozambique. The aim of this study was to detect and characterize extended-spectrum \u03b2-lactamase (ESBL) - and plasmid-mediated AmpC (pAmpC)-producing clinical strains of\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      at Maputo Central Hospital (MCH), a 1000-bed reference hospital in Maputo, Mozambique.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 230 clinical isolates of\n                      <jats:italic>E. coli<\/jats:italic>\n                      from urine (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009199) and blood cultures (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200931) were collected at MCH during August\u2013November 2015. Antimicrobial susceptibility testing was performed by the disc diffusion method and interpreted according to EUCAST guidelines. Isolates with reduced susceptibility to 3rd generation cephalosporins were examined further; phenotypically for an ESBL\u2212\/AmpC-phenotype by combined disc methods and genetically for ESBL- and pAmpC-encoding genes by PCR and partial amplicon sequencing as well as genetic relatedness by ERIC-PCR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 75 isolates with reduced susceptibility to cefotaxime and\/or ceftazidime (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200975) from urine (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200958\/199; 29%) and blood (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200917\/31; 55%) were detected. All 75 isolates were phenotypically ESBL-positive and 25\/75 (33%) of those also expressed an AmpC-phenotype. ESBL-PCR and amplicon sequencing revealed a majority of\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>CTX-M<\/jats:sub>\n                      (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200958\/75; 77%) dominated by\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>CTX-M-15<\/jats:sub>\n                      . All AmpC-phenotype positive isolates (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200925\/75; 33%) scored positive for one or more pAmpC-genes dominated by\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>MOX\/FOX<\/jats:sub>\n                      . Multidrug resistance (resistance \u2265 three antibiotic classes) was observed in all the 75 ESBL-positive isolates dominated by resistance to trimethoprim-sulfamethoxazole, ciprofloxacin and gentamicin. ERIC-PCR revealed genetic diversity among strains with minor clusters indicating intra-hospital spread.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      We have observed a high prevalence of MDR pAmpC- and\/or ESBL-producing clinical\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolates with FOX\/MOX and CTX-Ms as the major \u03b2-lactamase types, respectively. ERIC-PCR analyses revealed genetic diversity and some clusters indicating within-hospital spread. The overall findings strongly support the urgent need for accurate and rapid diagnostic services to guide antibiotic treatment and improved infection control measures.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05696-y","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T15:05:26Z","timestamp":1609945526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique"],"prefix":"10.1186","volume":"21","author":[{"given":"Calvina E. L.","family":"Estaleva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas F.","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Osei","family":"Sekyere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Govinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafizah Y.","family":"Chenia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar S.","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rg","family":"Haldorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabiha Y.","family":"Essack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3728-2270","authenticated-orcid":false,"given":"Arnfinn","family":"Sundsfjord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"issue":"2","key":"5696_CR1","doi-asserted-by":"crossref","first-page":"e001315","DOI":"10.1136\/bmjgh-2018-001315","volume":"4","author":"EY Klein","year":"2019","unstructured":"Klein EY, et al. Tracking global trends in the effectiveness of antibiotic therapy using the drug resistance index. BMJ Glob Health. 2019;4(2):e001315.","journal-title":"BMJ Glob Health"},{"issue":"9","key":"5696_CR2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.tim.2015.06.005","volume":"23","author":"H Gelband","year":"2015","unstructured":"Gelband H, Laxminarayan R. Tackling antimicrobial resistance at global and local scales. Trends Microbiol. 2015;23(9):524\u20136.","journal-title":"Trends Microbiol"},{"issue":"5","key":"5696_CR3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ijantimicag.2018.06.018","volume":"52","author":"A Russo","year":"2018","unstructured":"Russo A, et al. Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum beta-lactamase-producing Enterobacteriaceae. Int J Antimicrob Agents. 2018;52(5):577\u201385.","journal-title":"Int J Antimicrob Agents"},{"key":"5696_CR4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-micro-090110-102911","volume":"65","author":"K Bush","year":"2011","unstructured":"Bush K, Fisher JF. Epidemiological expansion, structural studies, and clinical challenges of new beta-lactamases from gram-negative bacteria. Annu Rev Microbiol. 2011;65:455\u201378.","journal-title":"Annu Rev Microbiol"},{"issue":"4","key":"5696_CR5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1128\/CMR.00023-13","volume":"26","author":"PL Woerther","year":"2013","unstructured":"Woerther PL, et al. Trends in human fecal carriage of extended-spectrum beta-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev. 2013;26(4):744\u201358.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"5696_CR6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/AAC.01009-09","volume":"54","author":"K Bush","year":"2010","unstructured":"Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010;54(3):969\u201376.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5696_CR7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/mdr.2010.0132","volume":"17","author":"U Naseer","year":"2011","unstructured":"Naseer U, Sundsfjord A. The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones. Microb Drug Resist. 2011;17(1):83\u201397.","journal-title":"Microb Drug Resist"},{"issue":"1","key":"5696_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","volume":"22","author":"GA Jacoby","year":"2009","unstructured":"Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev. 2009;22(1):161\u201382 Table of Contents.","journal-title":"Clin Microbiol Rev"},{"key":"5696_CR9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.plasmid.2018.09.010","volume":"99","author":"M Dolejska","year":"2018","unstructured":"Dolejska M, Papagiannitsis CC. Plasmid-mediated resistance is going wild. Plasmid. 2018;99:99\u2013111.","journal-title":"Plasmid"},{"issue":"1","key":"5696_CR10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1128\/AAC.00828-15","volume":"60","author":"T Cherif","year":"2016","unstructured":"Cherif T, et al. Cooccurrence of multiple AmpC beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis in Tunisia. Antimicrob Agents Chemother. 2016;60(1):44\u201351.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5696_CR11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4269\/ajtmh.2010.09-0578","volume":"83","author":"I Mandomando","year":"2010","unstructured":"Mandomando I, et al. Antimicrobial drug resistance trends of bacteremia isolates in a rural hospital in southern Mozambique. Am J Trop Med Hyg. 2010;83(1):152\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"5696_CR12","doi-asserted-by":"crossref","first-page":"e83591","DOI":"10.1371\/journal.pone.0083591","volume":"8","author":"TD Moon","year":"2013","unstructured":"Moon TD, et al. Bacteremia as a cause of fever in ambulatory, HIV-infected Mozambican adults: results and policy implications from a prospective observational study. PLoS One. 2013;8(12):e83591.","journal-title":"PLoS One"},{"issue":"9","key":"5696_CR13","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/jac\/dku176","volume":"69","author":"SJ Leopold","year":"2014","unstructured":"Leopold SJ, et al. Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review. J Antimicrob Chemother. 2014;69(9):2337\u201353.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"5696_CR14","doi-asserted-by":"crossref","first-page":"O255","DOI":"10.1111\/1469-0691.12373","volume":"20","author":"E Matuschek","year":"2014","unstructured":"Matuschek E, Brown DF, Kahlmeter G. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect. 2014;20(4):O255\u201366.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"5696_CR15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"5696_CR16","unstructured":"EUCAST, EUCAST guidelines for detection of resistance mechanims and specific resistances of clinical and\/or epidemiological importance, in www.eucast.org\/resistance_mechanisms\/. 2017. p. 4\u201311."},{"issue":"9","key":"5696_CR17","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1600-0463.2012.02898.x","volume":"120","author":"F Hansen","year":"2012","unstructured":"Hansen F, et al. Evaluation of ROSCO neo-Sensitabs for phenotypic detection and subgrouping of ESBL-, AmpC- and carbapenemase-producing Enterobacteriaceae. APMIS. 2012;120(9):724\u201332.","journal-title":"APMIS"},{"key":"5696_CR18","first-page":"332","volume":"132","author":"J Sharma","year":"2010","unstructured":"Sharma J, Sharma M, Ray P. Detection of TEM & SHV genes in Escherichia coli & Klebsiella pneumoniae isolates in a tertiary care hospital from India. Indian J Med Res. 2010;132:332\u20136.","journal-title":"Indian J Med Res"},{"issue":"2","key":"5696_CR19","first-page":"161","volume":"209","author":"M Saladin","year":"2002","unstructured":"Saladin M, et al. Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett. 2002;209(2):161\u20138.","journal-title":"FEMS Microbiol Lett"},{"issue":"6","key":"5696_CR20","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1128\/AAC.47.6.2056-2058.2003","volume":"47","author":"L Brinas","year":"2003","unstructured":"Brinas L, et al. Detection of CMY-2, CTX-M-14, and SHV-12 beta-lactamases in Escherichia coli fecal-sample isolates from healthy chickens. Antimicrob Agents Chemother. 2003;47(6):2056\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"5696_CR21","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/JCM.40.6.2153-2162.2002","volume":"40","author":"FJ Perez-Perez","year":"2002","unstructured":"Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40(6):2153\u201362.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"5696_CR22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12879-018-3154-1","volume":"18","author":"LM Chirindze","year":"2018","unstructured":"Chirindze LM, et al. Faecal colonization of E. coli and Klebsiella spp. producing extended-spectrum beta-lactamases and plasmid-mediated AmpC in Mozambican university students. BMC Infect Dis. 2018;18(1):244.","journal-title":"BMC Infect Dis"},{"issue":"24","key":"5696_CR23","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1093\/nar\/19.24.6823","volume":"19","author":"J Versalovic","year":"1991","unstructured":"Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 1991;19(24):6823\u201331.","journal-title":"Nucleic Acids Res"},{"key":"5696_CR24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13756-016-0117-4","volume":"5","author":"T Sonda","year":"2016","unstructured":"Sonda T, et al. Meta-analysis of proportion estimates of extended-Spectrum-Beta-lactamase-producing Enterobacteriaceae in East Africa hospitals. Antimicrob Resist Infect Control. 2016;5:18.","journal-title":"Antimicrob Resist Infect Control"},{"key":"5696_CR25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1476-0711-12-28","volume":"12","author":"SE Mshana","year":"2013","unstructured":"Mshana SE, Matee M, Rweyemamu M. Antimicrobial resistance in human and animal pathogens in Zambia, Democratic Republic of Congo, Mozambique and Tanzania: an urgent need of a sustainable surveillance system. Ann Clin Microbiol Antimicrob. 2013;12:28.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"9","key":"5696_CR26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.medmal.2015.08.003","volume":"45","author":"SA Sangare","year":"2015","unstructured":"Sangare SA, et al. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated from blood cultures in Africa. Med Mal Infect. 2015;45(9):374\u201382.","journal-title":"Med Mal Infect"},{"issue":"6","key":"5696_CR27","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3201\/eid1406.071168","volume":"14","author":"S Egorova","year":"2008","unstructured":"Egorova S, et al. Ceftriaxone-resistant salmonella enterica serotype Newport, France. Emerg Infect Dis. 2008;14(6):954\u20137.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"5696_CR28","first-page":"1","volume":"37","author":"R Ranjbar","year":"2014","unstructured":"Ranjbar R, et al. Typing methods used in the molecular epidemiology of microbial pathogens: a how-to guide. New Microbiol. 2014;37(1):1\u201315.","journal-title":"New Microbiol"},{"issue":"12","key":"5696_CR29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrurol.2010.190","volume":"7","author":"B Foxman","year":"2010","unstructured":"Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12):653\u201360.","journal-title":"Nat Rev Urol"},{"issue":"9","key":"5696_CR30","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/1469-0691.12028","volume":"19","author":"ME de Kraker","year":"2013","unstructured":"de Kraker ME, et al. The changing epidemiology of bacteraemias in Europe: trends from the European antimicrobial resistance surveillance system. Clin Microbiol Infect. 2013;19(9):860\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"5696_CR31","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S1473-3099(17)30394-8","volume":"17","author":"P Musicha","year":"2017","unstructured":"Musicha P, et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998-2016): a surveillance study. Lancet Infect Dis. 2017;17(10):1042\u201352.","journal-title":"Lancet Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05696-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05696-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05696-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T15:18:33Z","timestamp":1609946313000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05696-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5696"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05696-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.11665\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.11665\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.11665\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.11665\/v4","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"9 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Biomedical Research Ethics Committee of the University of KwaZulu-Natal (UKZN: BE 030\/16) and the Institutional Bioethics Committee for Health-CIBS- Instituto Superior de Ci\u00eancas de Sa\u00fade (ISCISA: TFCMCSCE 02\/15). The committees waived the requirements for informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SYE is a member of the Global Respiratory Infection Partnership sponsored by an unrestricted educational grant from Reckitt and Benckiser, UK.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}